Cambridge International Stem Cell Symposium 2020
8 September 2021 - 10 September 2021
We are proud to be sponsoring the Cambridge International Stem Cell Symposium in September 2020
The Symposium will bring together biological, clinical and physical stem cell scientists, working across multiple tissues and at different scales, to share data, discuss ideas and address the biggest fundamental and translational questions in stem cell biology.
The event, to be held at West Road Concert Hall, will feature leading stem cell researchers from around the world, including:
Sangeeta Bhatia (Massachusetts Institute of Technology), Fernando Camargo (Harvard Stem Cell Institute), John Dick (University of Toronto), Anne Grapin-Botton (Max Planck Institute of Molecular Cell Biology & Genetics), Peggy Goodell (Baylor College of Medicine), Kim Jensen (University of Copenhagen), Bill Keyes (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Carla Kim (Harvard Stem Cell Institute), Jürgen Knoblich (Institute of Molecular Biotechnology), Tsvee Lapidot (Weizmann Institute of Science), Prisca Liberali (Friedrich Miescher Institute for Biomedical Research), Matthias Lutolf (Ecole Polytechnique Fédérale de Lausanne), Samantha Morris (Washington University, St Louis), Charles Murry (University of Washington), Kathy Niakan (Francis Crick Institute), Shahragim Tajbakhsh (Institut Pasteur), Elly Tanaka (Research Institute of Molecular Pathology), Nan Tang (National Institute of Biological Sciences, Beijing), Sally Temple (Neural Stem Cell Institute, NY) Peter Zandstra (University of British Columbia).
This event is now postponed to 8-10 September 2021.
Mogrify® brings together a passionate and innovative team of world experts whose mission is to transform the future development of life-saving cell therapies, using our proprietary direct cellular conversion technology (Rackham et al., Nature Genetics, 2016), which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state. We will join the Cambridge International Stem Cell Symposium with the aim of discussing the role of stem cells in addressing the challenges associated with efficacy, safety, and scalability in the development and manufacture of new cell therapies. We will also be looking to connect with highly-skilled and ambitious individuals to join us on our journey delivering world-class science.